• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性淋巴结清扫术在胃癌根治性切除术中的预后重要性。

Prognostic importance of radical lymphadenectomy in curative resections for gastric cancer.

作者信息

Viste A, Svanes K, Janssen C W, Maartmann-Moe H, Søreide O

机构信息

Department of Surgery, University of Bergen, Norway.

出版信息

Eur J Surg. 1994 Sep;160(9):497-502.

PMID:7849169
Abstract

OBJECTIVE

To evaluate the effect of extensive lymphadenectomy on survival in patients with gastric cancer.

DESIGN

Retrospective analysis

SETTING

University Hospital, Norway.

SUBJECTS

183 patients with stomach cancer resected for cure during the time period 1980-90.

INTERVENTIONS

78 patients had an R1- and 105 patients and R2 resection. 124 patients were treated by total gastrectomy, 5 by proximal--and 54 by distal resection.

MAIN OUTCOME MEASURES

Morbidity, mortality and long term survival.

RESULTS

The morbidity was 33% (60/183), of which 39 (21%) were general complications (pneumonia, thrombosis, or cardiovascular disease). 14 patients died postoperatively (8%). By logistic regression analysis we found that splenectomy was the only variable associated with both morbidity and immediate postoperative mortality. Five year survival was 39% for patients who had undergone curative resections, 30% for patients who had had an R1 resection, and 47% for those who had had an R2 resection. By multivariate analysis (Cox) we found that N-classification (TNM), tumour diameter of less than 45 mm, type of lymph node dissection (R2) and operation period (after 1984) correlated with improved survival.

CONCLUSION

Extensive lymph node dissection improves survival without increasing morbidity or postoperative mortality.

摘要

目的

评估广泛淋巴结清扫术对胃癌患者生存率的影响。

设计

回顾性分析

地点

挪威大学医院

研究对象

1980年至1990年间因治愈目的而行胃癌切除术的183例患者。

干预措施

78例行R1切除,105例行R2切除。124例行全胃切除术,5例行近端胃切除术,54例行远端胃切除术。

主要观察指标

发病率、死亡率和长期生存率。

结果

发病率为33%(60/183),其中39例(21%)为全身并发症(肺炎、血栓形成或心血管疾病)。14例患者术后死亡(8%)。通过逻辑回归分析,我们发现脾切除术是与发病率和术后即刻死亡率均相关的唯一变量。根治性切除患者的五年生存率为39%,R1切除患者为30%,R2切除患者为47%。通过多因素分析(Cox法),我们发现N分期(TNM)、肿瘤直径小于45mm、淋巴结清扫类型(R2)和手术时间(1984年后)与生存率提高相关。

结论

广泛淋巴结清扫术可提高生存率,且不增加发病率或术后死亡率。

相似文献

1
Prognostic importance of radical lymphadenectomy in curative resections for gastric cancer.根治性淋巴结清扫术在胃癌根治性切除术中的预后重要性。
Eur J Surg. 1994 Sep;160(9):497-502.
2
Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.根治性D2淋巴结清扫术和脾切除术对手术治疗的胃癌患者的不同影响。
Hepatogastroenterology. 2000 Mar-Apr;47(32):579-85.
3
R2 compared with R1 resection for gastric cancer: morbidity and mortality in a prospective, randomised trial.胃癌R2与R1切除术对比:一项前瞻性随机试验中的发病率和死亡率
Eur J Surg. 1992 Aug;158(8):413-8.
4
Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.近端胃癌患者行保留脾脏的改良根治性淋巴结清扫术:与远端胃癌标准D2淋巴结清扫术的比较
J Surg Oncol. 2008 Dec 1;98(7):500-4. doi: 10.1002/jso.21137.
5
Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.扩大根治性淋巴结清扫术对胃癌患者的预后益处。
Anticancer Res. 2000 Mar-Apr;20(2B):1285-9.
6
[Long-term survival of curatively operated gastric cancer: influence of the gender and splenectomy].[胃癌根治术后的长期生存:性别和脾切除术的影响]
Zentralbl Chir. 2007 Dec;132(6):515-22. doi: 10.1055/s-2007-981373.
7
Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?扩大淋巴结清扫术对胃癌根治性切除术后的预后有影响吗?
Hepatogastroenterology. 2000 Sep-Oct;47(35):1470-4.
8
Gastric cancer: surgical management and prognosis.胃癌:手术治疗与预后
Ann Chir Gynaecol. 1996;85(4):293-8.
9
[Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].[胃癌根治性胃切除术联合脾切除术的长期疗效分析]
Zhonghua Wai Ke Za Zhi. 2005 Sep 1;43(17):1114-7.
10
Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.进展期胃癌患者行全胃切除联合脾切除/胰脾切除术的术后发病率/死亡率及生存率。
Hepatogastroenterology. 2004 Jan-Feb;51(55):298-302.

引用本文的文献

1
Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?胃癌的新辅助化疗:是必须,还是噱头?
World J Gastroenterol. 2018 Jan 14;24(2):274-289. doi: 10.3748/wjg.v24.i2.274.
2
Extent of lymph node dissection for adenocarcinoma of the stomach.胃癌腺癌的淋巴结清扫范围。
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD001964. doi: 10.1002/14651858.CD001964.pub4.
3
Postoperative adjuvant radiotherapy for patients with gastric adenocarcinoma.胃腺癌患者的术后辅助放疗。
J Gastric Cancer. 2012 Dec;12(4):205-9. doi: 10.5230/jgc.2012.12.4.205. Epub 2012 Dec 31.
4
R0 resection in the treatment of gastric cancer: room for improvement.胃癌的 R0 切除术:仍有改进空间。
World J Gastroenterol. 2010 Jul 21;16(27):3358-70. doi: 10.3748/wjg.v16.i27.3358.
5
Surgical treatment for gastric cancer in Turkish patients over age 70: early postoperative results and risk factors for mortality.土耳其 70 岁以上胃癌患者的手术治疗:术后早期结果和死亡风险因素。
Langenbecks Arch Surg. 2010 Nov;395(8):1101-6. doi: 10.1007/s00423-010-0625-2. Epub 2010 Mar 10.
6
Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer.胃癌胃切除术患者手术并发症的相关危险因素。
Clin Transl Oncol. 2006 May;8(5):354-61. doi: 10.1007/s12094-006-0182-x.
7
Factors related to lymph node metastasis and surgical strategy used to treat early gastric carcinoma.早期胃癌的淋巴结转移相关因素及手术治疗策略
World J Gastroenterol. 2004 Mar 1;10(5):737-40. doi: 10.3748/wjg.v10.i5.737.